Drug review: Fosfomycin—A rarely used but more practical approach for urinary tract infections

Abstract

In this current era of resistance, treating urinary tract infections (UTIs) on outpatient department (OPD) basis has become cumbersome. Resistance has dramatically increased for cotrimoxazole, levofloxacin, ciprofloxacin and nitrofurantoin in past few decades. Intravenous drugs increase the cost of treatment and patient may need hospitalization. We searched and analyzed the literature and found fosfomycin to be better alternative in resistant UTI as resistance to this drug is low and is cost-effective in comparison to available intravenous drugs.